istock-949432696-artur
Artur / iStockphoto.com
28 January 2019Americas

Merck signs DNA licensing deal with Vertex

German pharmaceutical company  Merck Group has granted US biotech firm  Vertex a licence to two DNA-dependent protein kinases (DNA-PK) inhibitors.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
11 March 2019   King’s College London has entered a licensing and collaboration agreement with US pharmaceutical company Merck & Co to develop new chronic pain medications.
Big Pharma
13 December 2018   France-based biotechnology company genOway has acquired the exclusive global rights to German pharmaceutical company Merck Group’s CRISPR patents, to be used in the production and sale of rodent models.